Stay a step ahead of HCC

At Guerbet, we want to partner with you across the HCC patient’s treatment pathway. Integrated solutions combine forces to help fight liver cancer. Advance patient progress decisively at each step from diagnosis to treatment and follow up. That means high quality diagnostic imaging, conventional TACE (transarterial chemoembolization), dedicated medical devices, and potential for ongoing monitoring without re-injection. We’re even working toward an ability to incorporate AI for HCC characterization.

Watch the video of our experts panel

Read the Interventional News Supplement
LiverLink^TM From Physicians Perspective

HCC Management by Guerbet

Explore more about the different steps below

^{Product registration and indication may vary from country to country, please refer to your local SmPC (Summary of Product Characteristics) or IFU (Instruction For Use).}

^{Products legal information
P22001171}